Skip to content

People taking a large number of non-HIV-related medications more likely to stop or change HIV drugs

New PrEP studies will be a challenge, statisticians warn

Model suggests HIV vaccine still has key role in ending AIDS

Cardiovascular disease risk is higher for people with hepatitis C

D:A:D study: long-term treatment with tenofovir associated with increased risk of serious liver disease

Electrocautery ablation only partially effective as a treatment for high-grade pre-cancerous anal lesions in HIV-positive gay men

High rates of cervical disease and low rates of screening among women with HIV in Denmark

Efavirenz-based treatment is safe and effective for young children with HIV exposed to nevirapine for PMTCT

PrEP, plus increased testing and treatment, could prevent nearly half of HIV infections in gay men in the UK by 2020